LifeMD Files Q1 2025 10-Q, Reports Revenue and Stock Details
Ticker: LFMDP · Form: 10-Q · Filed: May 6, 2025 · CIK: 948320
| Field | Detail |
|---|---|
| Company | Lifemd, INC. (LFMDP) |
| Form Type | 10-Q |
| Filed Date | May 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, revenue, preferred-stock
TL;DR
LifeMD Q1 2025 10-Q is in! Revenue figures and preferred stock details are out.
AI Summary
LifeMD, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported telehealth revenue and WorkSimpli revenue for the first quarter of 2025, comparing it to the same period in 2024. The filing also details preferred stock information, including Series A and Series B preferred stock as of March 31, 2025, and December 31, 2024.
Why It Matters
This filing provides investors with the latest financial performance data for LifeMD, Inc., including revenue streams and capital structure, crucial for assessing the company's current health and future prospects.
Risk Assessment
Risk Level: medium — The filing contains financial performance data and details on preferred stock, which are key indicators of a company's financial health and potential risks.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Latest quarterly financial data)
- 2025-01-01 — Reporting Period Start Date (Latest quarterly financial data)
- 2024-03-31 — Prior Year Q1 End Date (For year-over-year comparison)
Key Players & Entities
- LifeMD, Inc. (company) — Filer
- 20250331 (date) — Period of Report
- 20250506 (date) — Filing Date
- LFMD:TelehealthRevenueMember (dollar_amount) — Revenue Category
- LFMD:WorkSimpliRevenueMember (dollar_amount) — Revenue Category
- us-gaap:SeriesBPreferredStockMember (dollar_amount) — Preferred Stock Type
- us-gaap:SeriesAPreferredStockMember (dollar_amount) — Preferred Stock Type
FAQ
What were LifeMD's telehealth and WorkSimpli revenues for Q1 2025?
The filing indicates 'LFMD:TelehealthRevenueMember' and 'LFMD:WorkSimpliRevenueMember' for the period 2025-01-01 to 2025-03-31, though specific dollar amounts are not detailed in this header.
How do Q1 2025 revenues compare to Q1 2024?
The filing provides data points for both 'LFMD:TelehealthRevenueMember' and 'LFMD:WorkSimpliRevenueMember' for Q1 2025 (2025-01-01 to 2025-03-31) and Q1 2024 (2024-01-01 to 2024-03-31), allowing for comparison.
What is the status of LifeMD's Series B Preferred Stock as of March 31, 2025?
The filing references 'us-gaap:SeriesBPreferredStockMember' for the date 2025-03-31, indicating its presence in the capital structure.
How has LifeMD's Series A Preferred Stock changed between December 31, 2024, and March 31, 2025?
The filing shows data for 'us-gaap:SeriesAPreferredStockMember' for both 2025-03-31 and 2024-12-31, allowing for a comparison of its status over the quarter.
What was LifeMD's former name before June 22, 2018?
Prior to June 22, 2018, LifeMD, Inc. was formerly known as CONVERSION LABS, INC.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 6, 2025 regarding LifeMD, Inc. (LFMDP).